Compass Therapeutics, Inc. - ESG Rating & Company Profile powered by AI
This webpage displays a zero-cost ESG assessment for Compass Therapeutics, Inc.. Alternative companies in the scoring peer group for Compass Therapeutics, Inc. are shown. This report of Compass Therapeutics, Inc. uses data from across the web as well as from public filings by Compass Therapeutics, Inc..
Compass Therapeutics, Inc. in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.4; made up of an environmental score of 2.7, social score of 6.4 and governance score of 4.0.
4.4
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 868 | Trevena Inc | 4.5 | High |
| 868 | Urogen Pharma Ltd | 4.5 | High |
| 910 | Compass Therapeutics, Inc. | 4.4 | High |
| 910 | CanBas Co Ltd | 4.4 | High |
| 910 | CNS Pharmaceuticals Inc | 4.4 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Compass Therapeutics, Inc. have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Compass Therapeutics, Inc. disclose current and historical energy intensity?
Sign up for free to unlockDoes Compass Therapeutics, Inc. report the average age of the workforce?
Sign up for free to unlockDoes Compass Therapeutics, Inc. reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Compass Therapeutics, Inc. disclose its ethnicity pay gap?
Sign up for free to unlockDoes Compass Therapeutics, Inc. disclose cybersecurity risks?
Sign up for free to unlockDoes Compass Therapeutics, Inc. offer flexible work?
Sign up for free to unlockDoes Compass Therapeutics, Inc. have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Compass Therapeutics, Inc. disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Compass Therapeutics, Inc. conduct supply chain audits?
Sign up for free to unlockDoes Compass Therapeutics, Inc. disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Compass Therapeutics, Inc. conduct 360 degree staff reviews?
Sign up for free to unlockDoes Compass Therapeutics, Inc. disclose the individual responsible for D&I?
Sign up for free to unlockDoes Compass Therapeutics, Inc. disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Compass Therapeutics, Inc. disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Compass Therapeutics, Inc. disclose water use targets?
Sign up for free to unlockDoes Compass Therapeutics, Inc. have careers partnerships with academic institutions?
Sign up for free to unlockDid Compass Therapeutics, Inc. have a product recall in the last two years?
Sign up for free to unlockDoes Compass Therapeutics, Inc. disclose incidents of discrimination?
Sign up for free to unlockDoes Compass Therapeutics, Inc. allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Compass Therapeutics, Inc. issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Compass Therapeutics, Inc. disclose parental leave metrics?
Sign up for free to unlockDoes Compass Therapeutics, Inc. disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Compass Therapeutics, Inc. disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Compass Therapeutics, Inc. disclose the pay ratio of women to men?
Sign up for free to unlockDoes Compass Therapeutics, Inc. support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Compass Therapeutics, Inc. disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Compass Therapeutics, Inc. reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Compass Therapeutics, Inc. involved in embryonic stem cell research?
Sign up for free to unlockDoes Compass Therapeutics, Inc. disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Compass Therapeutics, Inc. disclose its waste policy?
Sign up for free to unlockDoes Compass Therapeutics, Inc. report according to TCFD requirements?
Sign up for free to unlockDoes Compass Therapeutics, Inc. disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Compass Therapeutics, Inc. disclose energy use targets?
Sign up for free to unlockDoes Compass Therapeutics, Inc. disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Compass Therapeutics, Inc. have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Compass Therapeutics, Inc.
These potential risks are based on the size, segment and geographies of the company.
Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascular endothelial growth factor A signaling pathways, which are critical to angiogenesis and tumor vascularization; and CTX-471, an IgG4 monoclonal antibody that is an agonist of CD137. Its product candidates also comprise CTX-8371, a bispecific inhibitor that targets PD-1 and PD-L1. The company was founded in 2014 and is headquartered in Boston, Massachusetts.